Fox Christine
Insider CIK 1998173 · TEVA EVP, U.S. Commercial
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2026-04-30 | 2026-05-04 | 21,258 | $35.31 | $750.6K | 63,647 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2026-03-05 | 2026-03-09 | 17,819 | — | $0 | 53,459 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2026-03-05 | 2026-03-09 | 17,819 | — | $0 | 92,829 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2026-03-05 | 2026-03-09 | 7,924 | $31.67 | $251.0K | 84,905 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | A Award deriv | 2026-03-04 | 2026-03-06 | 50,643 | — | $0 | 50,643 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2026-03-04 | 2026-03-06 | 20,461 | — | $0 | 40,923 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2026-03-04 | 2026-03-06 | 9,098 | $32.46 | $295.3K | 75,010 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2026-03-04 | 2026-03-06 | 20,461 | — | $0 | 84,108 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2025-11-20 | 2025-11-24 | 63,492 | — | $0 | 126,984 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2025-11-20 | 2025-11-24 | 63,492 | — | $0 | 91,876 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2025-11-20 | 2025-11-24 | 28,229 | $24.78 | $699.5K | 63,647 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2025-11-14 | 2025-11-18 | 30,000 | $25.11 | $753.3K | 28,384 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | A Award deriv | 2025-03-05 | 2025-03-07 | 71,278 | — | $0 | 71,278 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2025-03-05 | 2025-03-06 | 2,147 | $15.91 | $34.2K | 58,384 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2025-03-04 | 2025-03-06 | 20,461 | — | $0 | 61,384 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2025-03-04 | 2025-03-06 | 20,461 | — | $0 | 64,565 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2025-03-04 | 2025-03-06 | 4,034 | $15.73 | $63.5K | 60,531 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2024-11-20 | 2024-11-21 | 63,492 | — | $0 | 190,476 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2024-11-20 | 2024-11-21 | 63,492 | — | $0 | 63,492 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2024-11-20 | 2024-11-21 | 19,388 | $16.87 | $327.1K | 44,104 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | A Award deriv | 2024-03-04 | 2024-03-05 | 81,845 | — | $0 | 81,845 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | A Award deriv | 2023-11-20 | 2023-11-22 | 253,968 | — | $0 | 253,968 | SEC↗ |